Bluelinea SA (ALBLU) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.615x

Based on the latest financial reports, Bluelinea SA (ALBLU) has a cash flow conversion efficiency ratio of -0.615x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-434.85K ≈ $-508.39K USD) by net assets (€706.70K ≈ $826.20K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Bluelinea SA (ALBLU) liquidity interval to measure how many days the company can operate on defensive assets alone.

Bluelinea SA - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Bluelinea SA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Bluelinea SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bluelinea SA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Trimitra Propertindo Tbk PT JK:LAND	-0.029x
Osmosun SA PA:ALWTR	138.991x
Highfield Resources Ltd F:23H	-0.025x
ARGO BLOCKCHAIN SP.ADR/10 F:0XP0	N/A
Jwwinvest WAR:JWW	0.191x
Alfa Energi Investama Tbk PT JK:FIRE	0.043x
Eurasia Fonciere Investissements Société Anonyme PA:EFI	-0.015x
Jcurve Solutions Ltd AU:JCS	0.778x

Annual Cash Flow Conversion Efficiency for Bluelinea SA (2009–2024)

The table below shows the annual cash flow conversion efficiency of Bluelinea SA from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see ALBLU market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€1.41 Million ≈ $1.65 Million	€857.90K ≈ $1.00 Million	0.607x	+352.87%
2023-12-31	€2.68 Million ≈ $3.14 Million	€-644.38K ≈ $-753.35K	-0.240x	-2.49%
2022-12-31	€4.30 Million ≈ $5.03 Million	€-1.01 Million ≈ $-1.18 Million	-0.234x	-176.82%
2021-12-31	€-1.85 Million ≈ $-2.17 Million	€-565.52K ≈ $-661.15K	0.305x	+111.34%
2020-12-31	€886.46K ≈ $1.04 Million	€-2.39 Million ≈ $-2.79 Million	-2.691x	-2997.46%
2019-12-31	€2.27 Million ≈ $2.65 Million	€-196.87K ≈ $-230.16K	-0.087x	+41.82%
2018-12-31	€5.05 Million ≈ $5.91 Million	€-754.86K ≈ $-882.51K	-0.149x	+99.37%
2017-12-31	€6.35K ≈ $7.42K	€-149.58K ≈ $-174.88K	-23.557x	+90.18%
2016-12-31	€9.34K ≈ $10.92K	€-2.24 Million ≈ $-2.62 Million	-239.813x	-167621.39%
2015-12-31	€7.45K ≈ $8.71K	€-1.07K ≈ $-1.25K	-0.143x	+75.05%
2014-12-31	€2.92 Million ≈ $3.41 Million	€-1.67 Million ≈ $-1.96 Million	-0.573x	-30.80%
2013-12-31	€1.96 Million ≈ $2.29 Million	€-856.72K ≈ $-1.00 Million	-0.438x	-61.22%
2012-12-31	€2.22 Million ≈ $2.59 Million	€-602.23K ≈ $-704.07K	-0.272x	-51.44%
2009-12-31	€-367.77K ≈ $-429.97K	€66.00K ≈ $77.16K	-0.179x	--

About Bluelinea SA

PA:ALBLU France Medical Devices

Market Cap

$9.00 Million

€7.70 Million EUR

Market Cap Rank

#27306 Global

#472 in France

Share Price

€0.42

Change (1 day)

+0.00%

52-Week Range

€0.40 - €0.63

All Time High

€6.30